Keywords:
юрак ишемик касаллиги, сурункали юрак етишмовчилиги, TGFβ1, Arg25Pro, полиморфизм, чап қоринча, молекуляр-генетик маркер.References
1. Gichkun O.E., Shevchenko O.P., Kurabe-kova R.M., Mozheiko N.P., Shevchenko A.O. The rs1800470 Polymorphism of the TGFB1 Gene Is Associated with Myocardial Fibrosis in Heart Transplant Recipients. Acta Naturae. 2021;13(4):42–46.
2. Gichkun O.E., Kurabekova R.M., Shevchen-ko O.P., Koloskova N., Shevchenko A.O. Polymorphisms rs1800469, rs1800471 of the TGFB1 gene detected in patients with chronic heart failure who waiting cardiac transplantation. The 2022 TTS Congress. 2022.
3. Malinowski D., Bochniak O., Luterek-Pus-zyńska K., et al. Genetic Risk Factors Related to Coronary Artery Disease and Role of Transforming Growth Factor Beta 1 Polymorphisms. Genes. 2023; 14(7):1425.
4. Wang S.X., Feng Y.N., Feng S., et al. IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway. Acta Pharmacologica Sinica. 2022;43(10):2542–2549.
5. Chen X., Yang Q., Bai W., et al. Dapagliflozin attenuates myocardial fibrosis by inhibiting the TGF-β1/Smad signaling pathway in a normoglycemic rabbit model of chronic heart failure. Frontiers in Pharmacology. 2022;13: 87-108.
6. Xie J., et al. Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis. Nature Communications. 2022. doi: 10.1038/s41467-022-30630-y.
7. Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac Fibrosis. Pharmaceuticals. 2023;17(3):267.
8. Ganekal P., Vastrad B., Vastrad C., Kotrashetti S. Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis. Journal of International Medical Research. 2023.
9. Mukhopadhyay S., Dixit P., Khanom N., Sanghera G., McGurk K.A., et al. The Genetic Factors Influencing Cardiomyopathies and Heart Failure across the Allele Frequency Spectrum. Journal of Cardiovascular Translational Research. 2024;17: 1119–1139.
10. Arbelo E., Protonotarios A., Gimeno J.R., et al. 2023 ESC Guidelines for the management of cardiomyopathies. European Heart Journal. 2023;44 (37):3503–3626.